These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19070809)

  • 1. [Management of toxicities due to anti-angiogenic treatment of metastatic renal carcinoma].
    Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S315-9. PubMed ID: 19070809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.
    Frangié C; Lefaucheur C; Medioni J; Jacquot C; Hill GS; Nochy D
    Lancet Oncol; 2007 Feb; 8(2):177-8. PubMed ID: 17267332
    [No Abstract]   [Full Text] [Related]  

  • 3. [The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies].
    Ferrière JM; Wallerand H; Bernhard JC; Cornu JN; Rouprêt M; Ravaud A
    Prog Urol; 2008 Jul; 18 Suppl 4():S88-91. PubMed ID: 18706377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New treatment of metastatic renal cancer. The Danish Society of Clinical Oncology].
    Sengeløv L; Geertsen PF;
    Ugeskr Laeger; 2007 Mar; 169(12):1117. PubMed ID: 17394828
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-angiogenic therapy in renal cell carcinoma: Alone, in combination, or sequentially.
    Figlin RA
    Clin Adv Hematol Oncol; 2009 Oct; 7(10):662-5. PubMed ID: 20040906
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel therapeutics for metastatic renal cell carcinoma.
    Hutson TE; Figlin RA
    Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new medical treatment of metastatic renal cell carcinoma: a good debut, a lot of open questions.
    Ficarra V; Novara G
    Eur Urol; 2008 Aug; 54(2):252-5. PubMed ID: 18513851
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
    Ficarra V; Novara G
    Eur Urol; 2008 Aug; 54(2):324-5. PubMed ID: 18485580
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
    Van Poppel H
    Eur Urol; 2008 Aug; 54(2):324. PubMed ID: 18485572
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential therapies in metastatic renal cell carcinoma: option or strategy?
    Bracarda S; De Simone V
    Eur Urol; 2008 Dec; 54(6):1219-20; discussion 1221-2. PubMed ID: 18778889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal cell carcinoma and antiangiogenic agents: ongoing controversies are seeking answers for improvement of therapeutic management].
    Audenet F; Rouprêt M; Méjean A
    Prog Urol; 2009 Oct; 19(9):596-605. PubMed ID: 19800548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma: antiangiogenic therapies and management of the complications. A case report].
    Fendler JP; Malavaud B; Gimel P; Duclos B; Chevreau C; Pignot G
    Prog Urol; 2010 Mar; 20 Suppl 1():S27-32. PubMed ID: 20493440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will we be able to "cure" metastatic renal cell carcinoma like we cure testicular tumours?
    Kirkali Z
    Eur Urol; 2008 Oct; 54(4):712-4. PubMed ID: 18640767
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted molecular therapy for renal cell carcinoma.
    Lane BR; Rini BI; Novick AC; Campbell SC
    Urology; 2007 Jan; 69(1):3-10. PubMed ID: 17270598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Critical analysis of prognostic factors for metastatic renal cell carcinoma].
    Neuzillet Y; Coulange C
    Prog Urol; 2009 Jun; 19(6):383-8. PubMed ID: 19467456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibition in non-clear cell renal cancer.
    Stadler W
    Clin Adv Hematol Oncol; 2008 Jul; 6(7):507-9. PubMed ID: 18654117
    [No Abstract]   [Full Text] [Related]  

  • 17. Metastatic renal cell carcinoma to the orofacial region: A novel method to alleviate symptoms and control disease progression.
    Hamdoon Z; Jerjes W; Upile T; Akram S; Hopper C
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):246-50. PubMed ID: 21112547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of hypertension and heart failure due to antiangiogenic cancer therapies.
    Rees ML; Khakoo AY
    Heart Fail Clin; 2011 Jul; 7(3):299-311. PubMed ID: 21749882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadal vein tumor thrombus in metastatic renal cell carcinoma.
    Thomas AA; Herts BR; Campbell SC
    Urology; 2009 Jun; 73(6):1229-30. PubMed ID: 19375787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.